0000899243-22-001650.txt : 20220111 0000899243-22-001650.hdr.sgml : 20220111 20220111211124 ACCESSION NUMBER: 0000899243-22-001650 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220111 FILED AS OF DATE: 20220111 DATE AS OF CHANGE: 20220111 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vitorovic Stefan CENTRAL INDEX KEY: 0001826967 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41200 FILM NUMBER: 22525324 MAIL ADDRESS: STREET 1: C/O PRAXIS PRECISION MEDICINES, INC. STREET 2: ONE BROADWAY, 16TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vigil Neuroscience, Inc. CENTRAL INDEX KEY: 0001827087 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 TECHNOLOGY SQUARE STREET 2: 10TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 857-254-4445 MAIL ADDRESS: STREET 1: 400 TECHNOLOGY SQUARE STREET 2: 10TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-01-11 0 0001827087 Vigil Neuroscience, Inc. VIGL 0001826967 Vitorovic Stefan VIGIL NEUROSCIENCE, INC. 1 BROADWAY, 7TH FLOOR, SUITE 07-300 CAMBRIDGE MA 02142 1 0 0 0 Common Stock 2022-01-11 4 C 0 3333245 A 3333245 I By Vida Ventures III, L.P. Common Stock 2022-01-11 4 C 0 7684 A 7684 I By Vida Ventures III-A, L.P. Common Stock 2022-01-11 4 P 0 1671148 14.00 A 5004393 I By Vida Ventures III, L.P. Common Stock 2022-01-11 4 P 0 3852 14.00 A 11536 I By Vida Ventures III-A, L.P. Series B Preferred Stock 2022-01-11 4 C 0 9243756 0.00 D Common Stock 3333245 0 I By Vida Ventures III, L.P. Series B Preferred Stock 2022-01-11 4 C 0 21310 0.00 D Common Stock 7684 0 I By Vida Ventures III-A, L.P. Each share of Series B Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock") on a one-for-2.7732 basis upon the closing of the Issuer's initial public offering on January 11, 2022 and had no expiration date. The shares are held directly by Vida Ventures III, L.P. ("Vida III"). Vida Ventures GP III, L.L.C. ("Vida III GP") is the general partner of of Vida III. The Reporting Person is a managing member of Vida III GP and disclaims beneficial ownership of the shares held directly by Vida III, except to the extent of his pecuniary interest therein, if any. The shares are held directly by Vida Ventures III-A, L.P. ("Vida III-A"). Vida III GP is the general partner of of Vida III-A. The Reporting Person is a managing member of Vida III GP and disclaims beneficial ownership of the shares held directly by Vida III-A, except to the extent of his pecuniary interest therein, if any. On January 11, 2022, Vida III purchased 1,671,148 shares of Common Stock of the Issuer at a price of $14.00 per share pursuant to an underwritten public offering. On January 11, 2022, Vida III-A purchased 3,852 shares of Common Stock of the Issuer at a price of $14.00 per share pursuant to an underwritten public offering. /s/Jennifer Ziolkowski, Attorney-in-Fact 2022-01-11